Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Gani, Osman A. B. S. M.
Gruber, Franz X. E.
Engh, Richard A.
Funding for this research was provided by:
Norges Forskningsråd (191303)
Text and Data Mining valid from 2017-07-04
30 October 2016
18 June 2017
4 July 2017